comparemela.com

Latest Breaking News On - Syntranet core platform - Page 3 : comparemela.com

UpHealth, Inc (NYSE:UPH) Given Consensus Rating of Buy by Brokerages

Shares of UpHealth, Inc. (NYSE:UPH – Get Rating) have been given an average rating of “Buy” by the six brokerages that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price objective among brokerages […]

Accelera Innovations (OTCMKTS:ACNV) versus UpHealth (NYSE:UPH) Head to Head Analysis

Accelera Innovations (OTCMKTS:ACNV – Get Rating) and UpHealth (NYSE:UPH – Get Rating) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations. Valuation & Earnings This table compares Accelera Innovations and […]

Head-To-Head Review: UpHealth (NYSE:UPH) versus Better Therapeutics (NASDAQ:BTTX)

UpHealth (NYSE:UPH – Get Rating) and Better Therapeutics (NASDAQ:BTTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, dividends and institutional ownership. Valuation & Earnings This table compares UpHealth and Better Therapeutics’ […]

Analyzing UpHealth (NYSE:UPH) & Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ:PRVA – Get Rating) and UpHealth (NYSE:UPH – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations. Analyst Ratings This is a summary of recent ratings and […]

Oppenheimer Weighs in on UpHealth, Inc s Q1 2022 Earnings (NYSE:UPH)

UpHealth, Inc. (NYSE:UPH – Get Rating) – Oppenheimer cut their Q1 2022 earnings per share estimates for UpHealth in a report issued on Monday, April 18th. Oppenheimer analyst M. Wiederhorn now forecasts that the company will post earnings of ($0.06) per share for the quarter, down from their prior forecast of ($0.05). Oppenheimer also issued […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.